In a report released today, Andrew Sherman from TD Cowen reiterated a Buy rating on Axon Enterprise (AXON – Research Report), with a price target of $750.00.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Andrew Sherman has given his Buy rating due to a combination of factors that highlight Axon Enterprise’s strong performance and growth potential. The company reported a 31% revenue growth, surpassing expectations, and raised its fiscal year 2025 growth forecast. This positive outlook is supported by the successful launch of Draft One and the AI Plan, which are expected to see significant adoption. Additionally, the demand for TASER 10 remains robust, although it is currently limited by production capacity, prompting management to increase capital expenditure guidance to address this issue.
International bookings have reached record levels, indicating growing momentum in markets outside the U.S., where the penetration of TASER and body cameras is still relatively low. The company’s enterprise pipelines are also strong, driven by products like Fusus. Overall, management’s guidance appears conservative, with substantial upside potential, leading to an increased price target from $725 to $750. These factors collectively underpin Sherman’s confidence in Axon’s future performance.
In another report released on May 6, Barclays also maintained a Buy rating on the stock with a $726.00 price target.